Full Text Journal Articles by
Author Mackenzie L Shindorf

Advertisement

Find full text journal articles








Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection.

James D McDonald, Shreya Gupta, Mackenzie L Shindorf, Lauren A Gamble, Samantha M Ruff, Justin Drake, Theo Heller, Jim Y Wan, Paxton V Dickson, Evan S Glazer, Jeremy L Davis, Jeremiah L Deneve, Jonathan M Hernandez,

BACKGROUND:Fibrolamellar hepatocellular carcinoma (FLC) is a rare variant of hepatocellular carcinoma (HCC), with most clinical data stemming from single-institution series. The variability in the literature lends support for analysis using a large national dataset. In doing so, we sought to (1) define the characteristics and outcomes of patients with FLC; ... Read more >>

Ann. Surg. Oncol. (Annals of surgical oncology)
[2020, 27(6):1900-1905]

Cited: 0 times

View full text PDF listing >>



Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl.

Mackenzie L Shindorf, Prabir K Chaudhuri,

The standard of care for benign pheochromocytomas and paragangliomas is surgical resection; however, there is no definitive curative or standard therapy for the treatment of malignant pheochromocytomas or paragangliomas. Current therapeutic options include surgical resection, chemotherapy (CVD therapy), MIBG-radiotherapy, somatostatin analogues, and combination targeted therapies such as temozolomide and thalidomide. ... Read more >>

Case Rep Med (Case reports in medicine)
[2019, 2019:7185973]

Cited: 0 times

View full text PDF listing >>



Advertisement

Role of Surgery in Combination with Immunotherapy.

Nicholas D Klemen, Mackenzie L Shindorf, Richard M Sherry,

Improvements in systemic immunotherapy are changing the treatment of patients with advanced melanoma and many other tumors. Surgeons may be increasingly called on to manage isolated sites of immunorefractory disease or to provide palliative surgery as a bridge to systemic therapy. Here, the authors describe the biologic rationale for using ... Read more >>

Surg. Oncol. Clin. N. Am. (Surgical oncology clinics of North America)
[2019, 28(3):481-487]

Cited: 0 times

View full text PDF listing >>



The interaction of ifosfamide and aprepitant in gynecologic malignancies.

Mackenzie L Shindorf, Kelly J Manahan, John P Geisler,

•Aprepitant combined with ifosfamide may lead to encephalopathy.•Aprepitant-ifosfamide induced encephalopathy was of short duration in these cases. ... Read more >>

Gynecol Oncol Case Rep (Gynecologic oncology case reports)
[2013, 6:34-35]

Cited: 3 times

View full text PDF listing >>





Advertisement

Disclaimer
0.4835 s